ArticleBMC pharmacology & toxicology2025
A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS).
Luyao He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it